Catalyst Wire Dossier Catalyst Wire Dossier

Interferon-alpha2a

interferon alfa-2a · Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Interferon-alpha2a, covering 2008-03-04 to 2008-03-04. Get the full timeline:

Most recent: Clinical Trial Update: A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes [Phase 2]

See pricing